NCT00884585 - Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

July 31, 2011

Conditions

Atopic Conjunctivitis

Interventions

DRUG

Cyclosporine Vehicle

Placebo (cyclosporine vehicle) administered 4 times a day to the qualified eye(s) for 3 months.

DRUG

Cyclosporine 0.010%

Cyclosporine ophthalmic solution 0.010% administered 4 times a day to the qualified eye(s) for up to 12 months; at Month 9 the dose may be adjusted to 2 times a day.

Trial Locations (12)

Unknown

Bakersfield

Randwick

Ottawa

Prague

Dijon

Munich

Bangalore

Tel Aviv

Rome

Wellington

Valladolid

Newcastle upon Tyne